Uniseed
John Kurek is a seasoned investment director with extensive experience in the biotechnology sector and venture capital. Since March 2007, John has been with Uniseed, Australia's longest-running venture fund, serving as Investment Director and Manager. In addition, John holds several non-executive director positions at various clinical-stage biotechnology companies including Certa Therapeutics, Kinoxis Therapeutics, Exonate, OccuRx, Q-Sera Pty Ltd, Currus Biologics, Ena Respiratory, and Axelia Oncology. John’s educational background includes a PhD in Neuroscience from the University of Melbourne, along with degrees in Biochemistry and Drug Evaluation & Pharmaceutical Science.
This person is not in any teams
Uniseed
Uniseed is Australia’s longest-running venture fund, operating at the Universities of Melbourne, Queensland, Sydney & New South Wales, and the CSIRO, with investment capital provided by these research organisations and investment partners including a leading Australian Superannuation Fund, UniSuper. We are a unique commercialisation fund helping researchers from our partner research organisations turn their ideas into products and services. We support innovations that solve market problems and create a positive impact for our community. Uniseed invests over a broad range of technology sectors and has exited ten investments, to date.